Agent |
Dosage |
Adverse effects |
Special considerations |
Acitretin (oral retinoid) |
10-25 mg/d PO |
– Dry skin and mucous membranes – Retinoid dermatitis – Elevated liver enzymes – Hyperlipidemia – Teratogenicity |
Requires regular monitoring of liver function and lipids |
Methotrexate (folate antagonist) |
7.5-25 mg/wk PO or SC |
– Nausea, vomiting, and GI upset – Fatigue – Cytopenia – Mucositis – Hair loss – Hepatotoxicity – Increased risk of infections |
– Requires regular monitoring of blood count and liver and kidney function – Possible drug–drug interaction – Supplementation with folic acid may reduce certain adverse effects |
Cyclosporine (calcineurin inhibitor) |
3-5 mg/kg/d PO |
– Electrolyte imbalance (eg, hyperkalemia and hypomagnesemia) – Hyperuricemia – Dyslipidemia – Hypertension – Neurotoxicity (eg, headache, tremor, and peripheral neuropathy) – Nephrotoxicity – Hypertrichosis – Gingival hyperplasia – Increased risk of infection – Increased risk of malignancy |
– Requires regular blood count monitoring – Possible drug–drug interaction |
GI, gastrointestinal; PO, oral; SC, subcutaneous. |